Autonomic Testing in a Patient with Orthostatic Intolerance and Suspected Neuropathy
A 62-year-old woman with type 2 diabetes (15 years) reports 6 months of lightheadedness on standing, early satiety, and constipation alternating with diarrhea. Exam: supine BP 138/84, standing BP 104/70 at 3 minutes with heart rate rise from 68 to 74 bpm; she reports near-syncope. Quantitative sudomotor axon reflex testing (QSART) shows reduced sweat volumes at the forearm, proximal leg, and distal leg sites, with the distal leg most affected. Heart rate variability with deep breathing shows reduced respiratory sinus arrhythmia (expiratory-inspiratory ratio 1.06). Tilt-table testing reproduces symptoms with a gradual BP fall and blunted heart rate response. The patient asks whether her symptoms are 'just dehydration' and whether treatment should target blood pressure or something else.
1. How do the QSART, heart rate variability, and tilt-table findings localize the autonomic lesion, and how do they argue against simple dehydration?
Read the worked answer
QSART: Reduced sweat volumes at multiple sites with a distal-predominant pattern indicate postganglionic sudomotor (small-fiber) dysfunction, typical of diabetic autonomic neuropathy. A length-dependent pattern (distal leg worst) supports a peripheral small-fiber process.
Heart rate variability: A blunted expiratory-inspiratory ratio (1.06; normal generally >1.2) indicates reduced cardiovagal (parasympathetic) function.
Tilt table: Gradual BP fall with blunted heart rate response indicates a neurogenic component to orthostatic hypotension (failure of the baroreflex to mount a compensatory tachycardia), rather than the brisk tachycardia expected with simple volume depletion.
Against dehydration: Dehydration typically produces orthostatic tachycardia with preserved or exaggerated heart rate rise and preserved sudomotor function. Here, blunted HR response plus reduced QSART and reduced HR variability point to autonomic neuropathy (likely diabetic), not volume depletion alone. The judgment: the pattern is neurogenic orthostatic hypotension with small-fiber involvement.
2. What treatment approach follows from this localization, and what pitfalls should be avoided?
Read the worked answer
Approach: Nonpharmacologic measures first (fluid/salt, compression, slow rising, head-of-bed elevation, avoiding large carbohydrate meals and hot environments). If needed, pharmacologic therapy for neurogenic orthostatic hypotension (e.g., midodrine or droxidopa; fludrocortisone has limited evidence and can worsen supine hypertension). Treat the underlying diabetes and address gastrointestinal dysmotility symptomatically.
Pitfalls: (1) Pressor agents can cause supine hypertension - monitor supine BP. (2) Avoid attributing symptoms solely to dehydration and over-resuscitating with fluids without addressing neurogenic causes. (3) Avoid drugs that worsen orthostasis (alpha-blockers, diuretics, tricyclics). (4) Reassess for other causes of autonomic failure (e.g., amyloid, autoimmune) if the pattern is atypical or rapidly progressive. The judgment point: treatment is directed at the neurogenic mechanism, with monitoring for supine hypertension.